A condition in which a single non-encephalopathic demyelinatingThe process in which the protective coating of nerve tissue (i.e. myelin) becomes damaged or breaks down, causing nerve impulses to slow or halt that results in neurological problems. attack results in damage and neurological symptoms based onInflammation of the optic nerve that may be classified as unilateral (affecting one eye) or bilateral (affecting both eyes) that may result in vision changes, vision loss, and/or pain with eye movement. the location of the brain that became damaged. In the case of multiple sclerosis (MS)An autoimmune disease that attacks healthy cells in the myelin, the protective sheath that surrounds nerves in the central nervous system (CNS) leading to neurological symptoms originating from the brain, spinal cord, and/or optic nerve., if the attack meets criteria for MSAn autoimmune disease that attacks healthy cells in the myelin, the protective sheath that surrounds nerves in the central nervous system (CNS) leading to neurological symptoms originating from the brain, spinal cord, and/or optic nerve. by McDonald criteria, then it is determined to be MSAn autoimmune disease that attacks healthy cells in the myelin, the protective sheath that surrounds nerves in the central nervous system (CNS) leading to neurological symptoms originating from the brain, spinal cord, and/or optic nerve.. If it does not meet this MSAn autoimmune disease that attacks healthy cells in the myelin, the protective sheath that surrounds nerves in the central nervous system (CNS) leading to neurological symptoms originating from the brain, spinal cord, and/or optic nerve. criteria, then it remains CIS. However, many MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease patients with their first attack could technically meet criteria for MSAn autoimmune disease that attacks healthy cells in the myelin, the protective sheath that surrounds nerves in the central nervous system (CNS) leading to neurological symptoms originating from the brain, spinal cord, and/or optic nerve., but a trained neuroimmunologist would generally know the difference.
Clinically Isolated Syndrome (CIS)
Related Posts
Eight Years Old and Running for Her Brother
When Aria laced up her trainers for the AJ Bell Great Manchester Run, she wasn’t just racing — she was advocating for her twin brother
Global Leaders in MOGAD Research Convened May 14-16, 2026
Leading international clinicians, researchers, advocates, and industry collaborators gathered in Cambridge, Massachusetts, for two major back-to-back MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease meetings focused onInflammation of the optic nerve that may be classified as unilateral (affecting one eye) or bilateral (affecting both eyes) that may result in vision changes, vision loss, and/or pain with eye movement. research priorities, clinical trials, therapeutic
The State of MOGAD Science: Research, Treatments & What’s Next
The State of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Science: What We Learned Together This MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Awareness Month, we came together with the Siegel Rare NeuroimmuneA term that refers to the components of the immune system that acts in and affects the central nervous system. Association (SRNA) to host
